Kevin Wilson

1.8k total citations
29 papers, 723 citations indexed

About

Kevin Wilson is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kevin Wilson has authored 29 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kevin Wilson's work include Lung Cancer Treatments and Mutations (4 papers), Animal Nutrition and Physiology (4 papers) and Chromatin Remodeling and Cancer (2 papers). Kevin Wilson is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Animal Nutrition and Physiology (4 papers) and Chromatin Remodeling and Cancer (2 papers). Kevin Wilson collaborates with scholars based in United States, South Korea and United Kingdom. Kevin Wilson's co-authors include Paul M. Allen, K.R. Cramer, Richard Beyer, Brian D. Evavold, Jonathan B. Rothbard, J.S. Moritz, Thomas W. Ferkol, Daniel Rosenbluth, Daniel P. Schuster and Leland J McKinney and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Kevin Wilson

27 papers receiving 699 citations

Peers

Countries citing papers authored by Kevin Wilson

Since Specialization

Citations

This map shows the geographic impact of Kevin Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Wilson more than expected).

Fields of papers citing papers by Kevin Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Wilson. The network helps show where Kevin Wilson may publish in the future.

Co-authorship network of co-authors of Kevin Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Wilson. A scholar is included among the top collaborators of Kevin Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Wilson. Kevin Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 3230: Discovery of selective BRM (SMARCA2) ATPase inhibitors for the treatment of BRG1 (SMARCA4) mutant cancers 2024 ·Cancer Research ·Janice Y. Lee, Nathan A. Brooks, Brandon Antonakos, (unknown), (unknown), (unknown), (unknown), Zhifang Li, (unknown), Ross Wallace, (unknown), (unknown), (unknown), Maralee McVean, Gabrielle R. Kolakowski, (unknown), Kevin Wilson	1
2	Abstract PR015: Discovery of LY4050784 (FHD-909), a selective BRM (SMARCA2) ATPase inhibitor for the treatment of BRG1(SMARCA4) mutant cancers 2024 ·Molecular Cancer Therapeutics ·Janice Y. Lee, Nathan A. Brooks, Brandon Antonakos, (unknown), (unknown), (unknown), (unknown), Zhifang Li, (unknown), Ross Wallace, (unknown), (unknown), (unknown), Maralee McVean, Gabrielle R. Kolakowski, (unknown), Kevin Wilson	1
3	Discovery of a new series of PI3K-δ inhibitors from Virtual Screening 2021 ·Bioorganic & Medicinal Chemistry Letters ·Xavier Fradera, Qiaolin Deng, (unknown), (unknown), Solomon D. Kattar, Meredeth A. McGowan, Joey L. Methot, Kevin Wilson, Hua Zhou, (unknown), (unknown), Vincent Tong, Martin Augustin, Michael D. Altman, Charles A. Lesburg, Sanjiv Shah, Jason D. Katz	2
4	1296P BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC 2020 ·Annals of Oncology ·Stefanie S. Schalm, (unknown), Sangbin Lim, (unknown), (unknown), Rich Woessner, (unknown), Kevin Wilson, (unknown), Douglas Wilson, Brett Williams, John Campbell, Chris De Savi, Faith Stevison, (unknown), (unknown), Marion Dorsch, Klaus P. Hoeflich, (unknown)	43
5	384P BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC 2020 ·Annals of Oncology ·Stefanie S. Schalm, (unknown), Sangbin Lim, (unknown), (unknown), Rich Woessner, (unknown), Kevin Wilson, (unknown), Douglas Wilson, Brett Williams, John Campbell, Chris De Savi, Faith Stevison, (unknown), (unknown), Marion Dorsch, Klaus P. Hoeflich, Byoung Chul Cho	12
6	The impact of primary care access on mortality in lung cancer patients from Bronx, New York. 2018 ·Journal of Clinical Oncology ·Christopher Su, Vincent Chau, Balázs Halmos, Chirag Shah, Rasim Gucalp, Stuart H. Packer, Kevin Wilson, Román Pérez-Soler, Haiying Cheng	1
7	Abstract 2641: The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi-kinase inhibitors 2016 ·Cancer Research ·Rami Rahal, Erica N Evans, Wei Hu, Michelle Maynard, Paul Fleming, Lucian DiPietro, Joseph L. Kim, Michael P. Sheets, (unknown), Kevin Wilson, Nicolas Stransky, Jason D. Brubaker, Timothy J. Guzi, Nancy E. Kohl, Christoph Lengauer	10
8	Characteristics of HIV+ lung cancer cases in a large clinical population: Implications for lung cancer screening. 2014 ·Journal of Clinical Oncology ·Marina Shcherba, H. Dean Hosgood, Juan Lin, David B. Hanna, Uriel R. Felsen, Mindy Ginsberg, (unknown), Kevin Wilson, (unknown), Xiaonan Xue, Kathryn Anastos, Bilal Piperdi, Simon D. Spivack, Steven M. Keller, Howard D. Strickler, Missak Haigentz	0
9	Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy 2013 ·Journal of Pediatric Surgery ·Andrew J. Murphy, Gregory D. Ayers, Melissa A. Hilmes, Kaushik Mukherjee, Kevin Wilson, (unknown), Israel Fernández‐Pineda, Myrick C. Shinall, Zhiguo Zhao, Wayne L. Furman, M. Beth McCarville, Andrew M. Davidoff, Harold N. Lovvorn	13
10	Abstract P4-13-04: Estrogen and Avoidance of Invasive Breast Cancer, Coronary Heart Disease and All-cause Mortality. Public Health Impact of Estrogen Guidelines for Women entering Menopause. 2012 ·Cancer Research ·Joseph Ragaz, Kevin Wilson, (unknown), (unknown), Hiu Yung Wong	0
11	Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met 2011 ·Journal of Biological Chemistry ·Keith Rickert, Sangita B. Patel, Timothy J. Allison, Noel Byrne, Paul L. Darke, (unknown), David Guérin, Dawn L. Hall, Maria Kornienko, Jun Lu, Sanjeev Munshi, John C. Reid, Jennifer M. Shipman, (unknown), Kevin Wilson, (unknown), S.M. Soisson, Kevin J. Lumb	30
12	Shape analysis of 123I-N-ω-fluoropropyl-2-β-carbomethoxy-3β-(4-iodophenyl) nortropane single-photon emission computed tomography images in the assessment of patients with parkinsonian syndromes 2009 ·Nuclear Medicine Communications ·Roger T. Staff, Trevor Ahearn, Kevin Wilson, Carl Counsell, Kate Taylor, Robert Caslake, Joyce Davidson, H. G. Gemmell, Alison D. Murray	16
13	A New Pyridazine Series of GABA_A α5 Ligands 2005 ·Journal of Medicinal Chemistry ·Monique B. van Niel, Kevin Wilson, (unknown), John Atack, José L. Castro, (unknown), Stephen R. Fletcher, Ute Gerhard, (unknown), (unknown), Karen Maubach, Robert Newman, Desmond O’Connor, Gopalan V. Pillai, Peter B. Simpson, Steven R. Thomas, Angus M. MacLeod	10
14	Lung Function Decline in Cystic Fibrosis Patients and Timing for Lung Transplantation Referral 2004 ·CHEST Journal ·Daniel Rosenbluth, Kevin Wilson, Thomas W. Ferkol, Daniel P. Schuster	104
15	Effect of Sorghum-Based Diets Subjected to Various Manufacturing Procedures on Broiler Performance 2003 ·The Journal of Applied Poultry Research ·K.R. Cramer, Kevin Wilson, J.S. Moritz, Richard Beyer	22
16	Effect of Formulation Density, Moisture, and Surfactant on Feed Manufacturing, Pellet Quality, and Broiler Performance 2002 ·The Journal of Applied Poultry Research ·J.S. Moritz, Kevin Wilson, K.R. Cramer, Richard Beyer, Leland J McKinney, (unknown), (unknown)	50
17	Effect of Moisture Addition at the Mixer to a Corn-Soybean-Based Diet on Broiler Performance 2001 ·The Journal of Applied Poultry Research ·J.S. Moritz, Richard Beyer, Kevin Wilson, K.R. Cramer, Leland J McKinney, (unknown)	65
18	234 Importance of timing for thoracic irradiation (TI) in the combined modality treatment of limited-stage small-cell lung cancer (LSCLC): An update of the National Cancer Institute of Canada (NCIC) BR6 study 1997 ·Lung Cancer ·Nevin Murray, Benny Zee, Joseph L. Pater, P. Coy, I. Hodson, (unknown), Debbie Payne, Edmund Kostashuk, W.K. Evans, (unknown), Anna Sadura, R. Feld, Mark L. Levitt, Ryszard Wierzbicki, Jean-Pierre Ayoub, J. Maroun, Kevin Wilson	2
19	Specific T cell recognition of minimally homologous peptides: Evidence for multiple endogenous Ligands 1995 ·Immunity ·Brian D. Evavold, (unknown), Kevin Wilson, Jonathan B. Rothbard, Paul M. Allen	188
20	Serial D-dimer levels in the assessment of tumor mass and clinical outcome in ovarian cancer 1988 ·Gynecologic Oncology ·S. K. Khoo, D.B. Rylatt, Peter G. Parsons, Kevin Wilson, Mason Webb, (unknown), John H. Kearsley, E. V. Mackay	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact